Monday, August 14, 2017

Mass General Urologists on Prostate Cancer Screenings and Treatments (Videos)

About one in seven men will be affected by prostate cancer in their lifetime. Each year, 26,000 men die from prostate cancer. Learn how researchers and clinicians at Massachusetts General Hospital are helping to raise awareness of and to advance the screening and treatment of prostate cancer.

Video & News Features

Adam Scott Feldman, MD, MPH, Department of Urology, Massachusetts General Hospital

Adam Scott Feldman, MD, MPH
Department of Urology, Massachusetts General Hospital

Active Surveillance in Younger Men with Prostate Cancer (Onc Live)
Dr. Feldman discusses a study focused on active surveillance in men with prostate cancer under the age of 60.

Prostate Cancer Overview (Patient Education Video)
Dr. Feldman provides an overview of prostate cancer and information about screening in this informational video.

What is Prostate Biopsy? (Patient Education Video)
Dr. Feldman explains the prostate biopsy procedure, including how to prepare and what to expect.

Douglas Dahl, MD, Department of Urology, Massachusetts General Hospital

Douglas Dahl, MD
Chief, Division of Urologic Oncology, Massachusetts General Hospital

Updates in Prostate Cancer (Healthcasts)
Dr. Dahl discusses improvements in prostate cancer screening and treatments.

Prostate Cancer: Who to Treat and When to Treat (Healthcasts)
Dr. Dahl discusses the more patient-centered approach to prostate cancer treatment of the last ten years.

Prostate Cancer: Current and Emerging Treatments (Healthcasts)
The past ten years have seen refinements to protocols for prostate cancer treatments, including minimally invasive surgery and improved accuracy of radiation techniques and hormone treatment, and focal therapy as an emerging treatment.

Upcoming CMEs

State of the Art Imaging in the Diagnosis and Management of Prostate Cancer
Friday, October 20, 2017

This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI) scanning techniques, MRI-ultrasound fusion biopsy, and other recent advances in imaging technology for advanced and recurrent prostate cancer.

Register for CME    

Urotrack 2017
November 2-4, 2017
A state-of-the-art, advanced course highlighting current research and advancements in urology, featuring a keynote speech by Mass General Department of Urology chief Dr. Michael Blute. The Uro-Track CME is designed for urologists and clinicians interested in updating their knowledge in the diagnosis, evaluation and management of urologic diseases. Distinguished faculty from partnering institutions will present on topics including GU trauma, pediatric urology, prostate, bladder, kidney, incontinence and erectile dysfunction.

Register for CME    

Back to Top